Daiichi Sankyo Company, Limited

TSE:4568 Stock Report

Market Cap: JP¥10.5t

Daiichi Sankyo Company Past Earnings Performance

Past criteria checks 5/6

Daiichi Sankyo Company has been growing earnings at an average annual rate of 6.3%, while the Pharmaceuticals industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 10.1% per year. Daiichi Sankyo Company's return on equity is 11.9%, and it has net margins of 12.5%.

Key information

6.3%

Earnings growth rate

6.7%

EPS growth rate

Pharmaceuticals Industry Growth3.4%
Revenue growth rate10.1%
Return on equity11.9%
Net Margin12.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are

May 02
Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are

Recent updates

Here's Why Daiichi Sankyo Company (TSE:4568) Has Caught The Eye Of Investors

May 22
Here's Why Daiichi Sankyo Company (TSE:4568) Has Caught The Eye Of Investors

Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are

May 02
Statutory Profit Doesn't Reflect How Good Daiichi Sankyo Company's (TSE:4568) Earnings Are

Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 27
Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Daiichi Sankyo Company (TSE:4568) Is Paying Out A Larger Dividend Than Last Year

Mar 11
Daiichi Sankyo Company (TSE:4568) Is Paying Out A Larger Dividend Than Last Year

Daiichi Sankyo Company (TSE:4568) Will Pay A Larger Dividend Than Last Year At ¥30.00

Feb 26
Daiichi Sankyo Company (TSE:4568) Will Pay A Larger Dividend Than Last Year At ¥30.00

Revenue & Expenses Breakdown

How Daiichi Sankyo Company makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:4568 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,601,688200,731636,997365,169
31 Dec 231,503,471186,052578,348358,217
30 Sep 231,397,025147,885538,976357,008
30 Jun 231,348,996147,350511,428343,791
31 Mar 231,278,478109,188471,221341,570
31 Dec 221,182,20159,354435,551331,522
30 Sep 221,122,72462,816404,552301,836
30 Jun 221,061,14050,603375,565281,129
31 Mar 221,044,89266,972358,309260,228
31 Dec 211,034,69294,470357,377232,834
30 Sep 211,012,31386,756348,080231,885
30 Jun 21989,63879,321340,406232,560
31 Mar 21962,51675,958333,079227,353
31 Dec 20963,55270,599323,363224,168
30 Sep 20982,388116,315320,481216,129
30 Jun 20969,501117,584310,949205,104
31 Mar 20981,793129,074302,320197,465
31 Dec 19983,669148,891287,414198,066
30 Sep 19962,440113,821279,588195,904
30 Jun 19953,219112,805275,245199,435
31 Mar 19929,71793,409277,695203,711
31 Dec 18922,22866,479283,615203,000
30 Sep 18937,64870,018290,411206,117
30 Jun 18946,82955,081296,677233,531
31 Mar 18960,19560,282301,845236,046
31 Dec 17961,76637,887298,758246,479
30 Sep 17966,50938,758300,781242,153
30 Jun 17953,25552,017303,760215,721
31 Mar 17955,12453,466302,475214,347
31 Dec 16962,29659,736316,918214,027
30 Sep 16965,68160,572325,970216,074
30 Jun 16989,00177,951326,613211,564
31 Mar 16986,44682,282328,755208,656
31 Dec 15839,75955,256269,399186,615
30 Sep 15872,74467,132284,021190,206
30 Jun 15903,34061,708306,873191,180
31 Mar 15919,37246,762331,195190,666
31 Dec 141,149,34288,276266,861333,388
30 Sep 141,127,23380,437405,500185,139
30 Jun 141,120,17769,910361,139234,391
31 Mar 141,118,24160,943413,187191,212
31 Dec 131,059,28790,021419,188183,047
30 Sep 131,030,09673,097403,936190,699
30 Jun 131,007,74757,234405,190183,047

Quality Earnings: 4568 has high quality earnings.

Growing Profit Margin: 4568's current net profit margins (12.5%) are higher than last year (8.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4568's earnings have grown by 6.3% per year over the past 5 years.

Accelerating Growth: 4568's earnings growth over the past year (83.8%) exceeds its 5-year average (6.3% per year).

Earnings vs Industry: 4568 earnings growth over the past year (83.8%) exceeded the Pharmaceuticals industry 13.3%.

Return on Equity

High ROE: 4568's Return on Equity (11.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.